Experimental cancer drug enters first human trials
NCT ID NCT05352750
Summary
This is the first human study of an experimental drug called SON-1010 for adults with advanced solid tumors that have stopped responding to standard treatments. Researchers will test increasing doses in 42 patients to find the safest amount and understand how the drug works in the body. The main goal is to check for side effects and determine the maximum safe dose before future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sarcoma Oncology Center
Santa Monica, California, 90403, United States
Conditions
Explore the condition pages connected to this study.